CSIMarket
 


Corvus Pharmaceuticals Inc   (CRVS)
Other Ticker:  
 

Cumulative Corvus Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period

CRVS's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CRVS Quick Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Growth -36.11 % -47.78 % -22.63 % -10.52 % 10.94 %
Y / Y Cash & cash equivalent Growth -35.82 % -35.17 % -34.74 % -45.24 % -39.09 %
Quick Ratio for Trailing Twelve Months Period 4.31 4.27 4 4.24 4.79
Total Ranking # 252 # 550 # 645 # 693 # 726
Seq. Current Liabilities Growth -5.89 % -7.11 % -5.21 % -22.9 % -23.08 %
Seq. Cash & cash equivalent Growth -15.6 % -13.1 % 7.4 % -18.52 % -14.74 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Current Liabilities decreased faster than Corvus Pharmaceuticals Inc 's average Cash & cash equivalent, this led to increase in in Corvus Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period to 4.31, Quick Ratio for Trailing Twelve Months Period remained below Corvus Pharmaceuticals Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Corvus Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about CRVS
Quick Ratio CRVS in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 79
Sector # 151
S&P 500 # 269


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
14.63 8 4
(Dec 31 2018)   (Jun 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Compass Pathways Plc  11.81 
Cryoport inc   11.70 
Adicet Bio Inc   11.68 
Kinnate Biopharma Inc   11.66 
Xenetic Biosciences Inc   11.63 
Pardes Biosciences Inc   11.61 
Aerovate Therapeutics Inc   11.57 
Ocuphire Pharma Inc   11.47 
Inozyme Pharma Inc   11.40 
Dianthus Therapeutics Inc   11.31 
Cymabay Therapeutics Inc   11.26 
Lianbio  11.19 
Cerevel Therapeutics Holdings Inc   11.18 
Erasca Inc   11.12 
Prelude Therapeutics Inc  11.08 
Lexaria Bioscience Corp   11.02 
Caladrius Biosciences Inc   10.99 
Roivant Sciences Ltd   10.99 
Eledon Pharmaceuticals Inc   10.94 
Protagonist Therapeutics inc   10.92 
Rocket Pharmaceuticals Inc   10.83 
Cormedix Inc   10.77 
Matinas Biopharma Holdings Inc   10.67 
Acasti Pharma Inc   10.65 
Sage Therapeutics Inc   10.58 
Milestone Pharmaceuticals inc   10.44 
Sinovac Biotech Ltd  10.37 
Kalvista Pharmaceuticals Inc   10.32 
Reneo Pharmaceuticals Inc   10.29 
Cytokinetics Incorporated  10.28 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com